首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1828110

2025年全球藥物輸注系統市場報告

Drug Infusion Systems Global Market Report 2025

出版日期: 2025年09月11日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，藥物輸液系統市場呈現強勁成長勢頭，市場規模從2024年的134.2億美元增至2025年的142.3億美元，複合年成長率達6.1%。這段時期的成長可歸因於向電子輸液設備的轉變、慢性病盛行率的上升、患者照護的進步、居家輸液治療以及門診照護環境的擴展。

預計未來幾年藥物輸液系統市場將強勁成長，2029年將達到202.3億美元，年複合成長率（CAGR）為9.2%。預測期內的成長動力包括：向一次性系統的轉變、慢性病盛行率的上升、門診護理設施的擴張、個人化醫療和自適應劑量以及居家照護需求的不斷成長。預測期內的主要趨勢包括無線連接和遠端監控、電子健康記錄（EHR）整合、智慧型幫浦技術、個人化醫療和自適應劑量以及微創輸液技術。

藥物輸注系統屬於醫療設備，它透過導管或針頭將藥物和液體輸送到病人體內。這種輸送方式通常用於醫院、診所和各種醫療機構，用於輸送止痛藥、抗生素、化療藥物和液體等藥物給病人。

藥物輸注系統的主要類別包括彈性輸注系統、一次性輸注系統、注射器輸注系統、蠕動幫浦、多通道幫浦、病人自控鎮痛 (PCA) 幫浦、胰島素幫浦和植入式輸注系統。例如，彈性輸注系統是一種靈活的容器，旨在以恆定速率輸送藥物，用於短期輸注治療。它們用於醫院、診所和家庭護理環境中的短期藥物輸注治療。這些多功能系統可以透過各種方法給藥，包括靜脈、皮下、動脈內和顱外給藥。它們服務於廣泛的醫療應用，包括化療、化療、糖尿病、鎮痛、營養、血液學和小兒科。各種最終用戶，包括醫院、門診手術中心和診斷中心，都利用彈性輸注系統來滿足他們的特定需求。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供藥物輸液系統市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的藥物輸液系統細分市場、市場趨勢和商機，以及在藥物輸液系統行業取得成功所需的數據。本藥物輸液系統市場研究報告提供您所需的全面展望，並詳細分析了該行業的現狀和未來趨勢。

未來五年的預測成長率為9.2%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自奧地利和英國等主要地區的蠕動泵裝置和阻塞檢測感測器徵收關稅直接影響美國，從而導致化療輸送挑戰和腫瘤治療成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

慢性病盛行率的上升預計將推動未來藥物輸注系統市場的擴張。癌症、糖尿病、心血管疾病和自體免疫疾病等慢性疾病通常需要長期或持續輸注治療。藥物輸注系統為這些疾病患者提供了一種安全、高效且有效的給藥方式。中低收入國家的慢性病盛行率成長速度快於高所得國家。糖尿病是導致腎衰竭、心臟病發作、中風、失明和下肢截肢的主要原因。例如，根據美國疾病管制與預防中心 (CDC) 2024 年 2 月的一份報告，患有多種慢性病的美國數量正在增加，42% 的人報告患有兩種或兩種以上的疾病，12% 的人報告患有五種或五種以上的疾病。因此，慢性病盛行率的上升正在推動藥物輸注系統市場的成長。

預計不斷成長的醫療支出將在未來幾年推動藥物輸注系統市場的成長。醫療支出是指在特定期間（通常為一年）內分配給醫療保健商品和服務的總金額。隨著醫療支出的增加，醫院、診所和其他醫療機構將有資源投資於先進的藥物輸注系統，增加對這些設備的需求。例如，2024 年 5 月，英國國家統計機構國家統計局 (ONS) 報告稱，從 2022 年到 2023 年，醫療保健總支出名義上將增加 5.6%，但 2022 年的成長率僅為 0.9%。因此，預計不斷成長的醫療支出將推動藥物輸注系統市場的成長。

藥物輸液系統市場的主要企業正專注於開發先進技術，例如雲端基礎的輸液管理系統，旨在改善患者照護、提高準確性並簡化輸液治療的管理。雲端基礎的輸液管理系統是數位平台，可透過雲端監控、管理和追蹤藥物輸液。例如，2023 年 6 月，先進輸液治療和藥物輸送解決方案的全球領導者 Eitan Medical（美國）推出了 Eitan Insights，這是一款新的雲端基礎的輸液管理系統，旨在滿足家庭輸液和專業輸液的特殊需求。 Eitan Insights 為醫療保健專業人員提供即時數據和分析，使他們能夠遠端監控患者並根據需要調整治療計劃。該系統透過最大限度地降低錯誤風險和提高對制定的協議的遵守來提高用藥安全性。

為了獲得競爭優勢，藥物輸注系統市場的主要參與企業正專注於開發創新產品，例如藥物輸送系統。藥物輸送系統包括各種創新工具和系統，旨在增強藥物管理的安全、準確和高效。例如，2023年2月，中國醫療設備製造商邁瑞醫療國際有限公司推出了BeneFusion i/u系列輸液系統。這些系統提供無與倫比的精確度、靈活的客製化和卓越的簡單性，確保各種臨床環境下的藥物安全。 BolusGUARD電子注射器裝載系統採用正在申請專利的自動離合器技術，可避免裝載錯誤並確保輸液過程每一步的準確性。其方便用戶使用的介面和直覺的設計簡化了工作流程並提升了用戶體驗。

2022年3月，總部位於德國的製藥公司費森尤斯卡比（Fresenius Kabi）以2.4億美元收購了Ivenix公司。此次策略性收購旨在擴大費森尤斯卡比的輸液治療產品組合，並鞏固其在輸液系統市場的地位。透過此次收購，費森尤斯卡比將提供全面、先進的優質輸液治療產品，造福病患、客戶和相關人員。被收購的Ivenix是一家總部位於美國的醫療技術公司，專門從事輸液系統的開發。

藥物輸液系統市場的主要企業包括美敦力公司、百特國際公司、ICU Medical Inc.、Becton Dickinson and Company、Smiths Group plc、Tandem Diabetes Care Inc.、Terumo Corporatio、Halyard Health Inc.、Insulet Corporation、Zyno Medical Inc.、Braun Melsungen AG、 KGaA、強生公司、Hospira、Alaris Health Systems Inc.、B. Braun Melsungen AG、Disetronic Medical Systems AG、Accu-Chek、Abbott Diabetes Care Inc.、Novo Nordisk A/S、Eli Lilly and Company、Sanofi-Aventis Care Inc.、Novo Nordisk A/S、Eli Lilly and Company、Sanofi-Aventis、Ypsomed Holding AG 和 Valeritas Inc.

2024年，北美是藥物輸液系統市場最大的地區。根據全球藥物輸液系統市場報告，預計亞太地區在預測期內將成為成長最快的地區。此藥物輸液系統市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。

藥物輸液系統市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

藥物輸注系統市場涵蓋智慧幫浦、注射式幫浦、腸內輸注系統和局部輸注系統的銷售。該市場的價值指的是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

全球藥物輸液系統：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
最終用途產業分析
全球藥物輸注系統市場：成長率分析
全球藥物輸注系統市場表現：規模與成長，2019-2024
全球藥物輸注系統市場預測：規模與成長，2024-2029年，2034年
全球藥物輸注系統：總潛在市場（TAM）

第6章市場細分

全球藥物輸注系統市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
彈性體注射系統
一次性輸液系統
注射器注射系統
蠕動幫浦
多通道泵浦
病人自控鎮痛（PCA）泵
胰島素幫浦
植入式輸液系統
全球藥物輸注系統市場（依給藥途徑）：2019-2024 年、2024-2029 年、2034 年績效及預測
靜脈
皮下
動脈
硬脊膜外麻醉
其他
全球藥物輸注系統市場的應用、績效與預測（2019-2024 年、2024-2029 年、2034 年）
腫瘤學和化療
糖尿病
止痛藥
營養
血液學
孩子們
其他
全球藥物輸注系統市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
醫院
門診手術中心
診斷中心
其他
全球藥物輸液系統市場：彈性輸液系統細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
無排氣彈性體泵
排氣彈性體泵
全球藥物輸液系統市場：一次性輸液系統細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
一次性輸液泵
一次性部件輸液器
全球藥物注射系統市場：注射器注射系統細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
手動注射輸液幫浦
電動注射輸液幫浦
全球藥物輸注系統市場：蠕動幫浦細分市場、類型、性能及預測（2019-2024、2024-2029、2034）
單通道蠕動泵
多通道蠕動泵
全球藥物輸注系統市場：多通道幫浦細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
通用多通道輸液泵
用於特定治療的多通道泵
全球藥物輸注系統市場：病患自控鎮痛 (PCA) 幫浦細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
電子PCA泵
機械PCA泵
全球藥物輸注系統市場：胰島素幫浦細分、類型、效能及預測（2019-2024、2024-2029、2034）
持續皮下胰島素輸注（CSII）泵
貼片式胰島素幫浦
全球藥物輸注系統市場：植入式輸注系統細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
用於治療慢性疼痛的植入式泵
植入式化療泵

第7章區域和國家分析

全球藥物輸注系統市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球藥物輸注系統市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

藥物輸注系統市場：競爭格局
藥物輸注系統市場：公司簡介
- Medtronic plc
- Baxter International Inc.
- ICU Medical Inc.
- Becton Dickinson and Company
- Smiths Group plc

第31章：其他領先和創新企業

Tandem Diabetes Care Inc.
Terumo Corporation
Halyard Health Inc.
Insulet Corporation
Zyno Medical Inc.
Braun Melsungen AG
Flowonix Medical Inc.
IRadimed Corporation
Moog Inc.
DebIoTech SA
Fresenius SE & Co. KGaA
Johnson & Johnson
Hospira
Alaris Health Systems Inc.
B. Braun Melsungen AG

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

2029年藥物輸注系統市場：提供新機會的國家
2029年藥物輸注系統市場：細分市場帶來新機會
2029年藥物輸注系統市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r24097u

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from $13.42 billion in 2024 to $14.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to shift to electronic infusion devices, increased prevalence of chronic diseases, patient care advancements, home-based infusion therapy, expansion of ambulatory care settings.

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $20.23 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to shift towards disposable systems, rising prevalence of chronic diseases, expansion of ambulatory care facilities, personalized medicine and adaptive dosing, increasing demand for home-based care. Major trends in the forecast period include wireless connectivity and remote monitoring, integration with electronic health records (ehr), smart pump technology, personalized and adaptive dosing, minimally invasive infusion techniques.

The forecast of 9.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on peristaltic pump mechanisms and occlusion detection sensors, sourced from key regions such as Austria and the UK, which could lead to chemotherapy delivery challenges and increased oncology treatment costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic diseases is anticipated to drive the expansion of the drug infusion system market in the future. Chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders frequently necessitate long-term or continuous infusion therapy. Drug infusion systems provide a safe, efficient, and effective means of delivering medication to patients with these conditions. The prevalence of chronic diseases is rising more rapidly in low- and middle-income countries compared to high-income nations. Diabetes, in particular, is a significant contributor to renal failure, heart attacks, strokes, blindness, and lower limb amputations. For example, in February 2024, reports from the Centers for Disease Control and Prevention (CDC), a U.S.-based organization, indicated that an increasing number of Americans are dealing with multiple chronic conditions, with 42% reporting two or more conditions and 12% experiencing five or more. Therefore, the rising prevalence of chronic diseases is driving the growth of the drug infusion system market.

The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.

Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

Major players in the drug infusion systems market are directing their efforts towards developing innovative products, such as medication delivery systems, to gain a competitive advantage. Medication delivery systems encompass a diverse range of innovative tools and systems designed to enhance the safe, accurate, and efficient administration of medications. For instance, in February 2023, Mindray Medical International Limited, a China-based manufacturer of medical instrumentation, launched the BeneFusion i/u Series Infusion Systems. These systems provide unparalleled accuracy, adaptive customization, and remarkable simplicity, ensuring guaranteed medication safety in various clinical settings. The BolusGUARD motorized syringe loading system with patent-pending automatic clutch technology prevents loading errors, securing every step of the infusion process. The user-friendly interface and intuitive design streamline workflows and enhance the user experience.

In March 2022, Fresenius Kabi, a pharmaceutical company based in Germany, acquired Ivenix Inc. for $240 million. This strategic acquisition aims to expand Fresenius Kabi's portfolio of infusion therapy products and strengthen its position in the infusion system market. The acquisition positions Fresenius Kabi to offer a comprehensive and leading set of premium infusion therapy products for the benefit of patients, customers, and stakeholders. Ivenix, the acquired company, is a medical technology company based in the United States, specializing in the development of infusion systems.

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

North America was the largest region in the drug infusion systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Infusion Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug infusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
Subsegments:
1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps
2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
Companies Mentioned: Medtronic plc; Baxter International Inc.; ICU Medical Inc.; Becton Dickinson and Company; Smiths Group plc; Tandem Diabetes Care Inc.; Terumo Corporation; Halyard Health Inc.; Insulet Corporation; Zyno Medical Inc.; Braun Melsungen AG; Flowonix Medical Inc.; IRadimed Corporation; Moog Inc.; Debiotech S.A.; Fresenius SE & Co. KGaA; Johnson & Johnson; Hospira; Alaris Health Systems Inc.; B. Braun Melsungen AG; Disetronic Medical Systems AG; Accu-Chek; Abbott Diabetes Care Inc.; Novo Nordisk A/S; Eli Lilly and Company; Sanofi-Aventis; Ypsomed Holding AG; Valeritas Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Drug Infusion Systems Market Characteristics

3. Drug Infusion Systems Market Trends And Strategies

4. Drug Infusion Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Infusion Systems Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Infusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Infusion Systems Market Growth Rate Analysis
5.4. Global Drug Infusion Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Infusion Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Infusion Systems Total Addressable Market (TAM)

6. Drug Infusion Systems Market Segmentation

6.1. Global Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Elastomeric Infusion System
Disposable Infusion System
Syringe Infusion System
Peristaltic Pump
Multi-Channel Pump
Patient-Controlled Analgesia (PCA) Pump
Insulin Pump
Implantable Infusion System
6.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
Arterial
Epidural
Other Routes Of Administration
6.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology And Chemotherapy
Diabetes
Analgesia
Nutrition
Hematology
Pediatrics
Other Applications
6.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Other End Users
6.5. Global Drug Infusion Systems Market, Sub-Segmentation Of Elastomeric Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Vented Elastomeric Pumps
Vented Elastomeric Pumps
6.6. Global Drug Infusion Systems Market, Sub-Segmentation Of Disposable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disposable Infusion Pumps
IV Sets With Disposable Components
6.7. Global Drug Infusion Systems Market, Sub-Segmentation Of Syringe Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manual Syringe Infusion Pumps
Electric Syringe Infusion Pumps
6.8. Global Drug Infusion Systems Market, Sub-Segmentation Of Peristaltic Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Channel Peristaltic Pumps
Multi-Channel Peristaltic Pumps
6.9. Global Drug Infusion Systems Market, Sub-Segmentation Of Multi-Channel Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Multi-Channel Infusion Pumps For General Use
Multi-Channel Pumps For Specific Therapies
6.10. Global Drug Infusion Systems Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electronic PCA Pumps
Mechanical PCA Pumps
6.11. Global Drug Infusion Systems Market, Sub-Segmentation Of Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Continuous Subcutaneous Insulin Infusion (CSII) Pumps
Patch Insulin Pumps
6.12. Global Drug Infusion Systems Market, Sub-Segmentation Of Implantable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implantable Pumps For Chronic Pain
Implantable Pumps For Chemotherapy

7. Drug Infusion Systems Market Regional And Country Analysis

7.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Infusion Systems Market

8.1. Asia-Pacific Drug Infusion Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Infusion Systems Market

9.1. China Drug Infusion Systems Market Overview
9.2. China Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Infusion Systems Market

10.1. India Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Infusion Systems Market

11.1. Japan Drug Infusion Systems Market Overview
11.2. Japan Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Infusion Systems Market

12.1. Australia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Infusion Systems Market

13.1. Indonesia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Infusion Systems Market

14.1. South Korea Drug Infusion Systems Market Overview
14.2. South Korea Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Infusion Systems Market

15.1. Western Europe Drug Infusion Systems Market Overview
15.2. Western Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Infusion Systems Market

16.1. UK Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Infusion Systems Market

17.1. Germany Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Infusion Systems Market

18.1. France Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Infusion Systems Market

19.1. Italy Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Infusion Systems Market

20.1. Spain Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Infusion Systems Market

21.1. Eastern Europe Drug Infusion Systems Market Overview
21.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Infusion Systems Market

22.1. Russia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Infusion Systems Market

23.1. North America Drug Infusion Systems Market Overview
23.2. North America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Infusion Systems Market

24.1. USA Drug Infusion Systems Market Overview
24.2. USA Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Infusion Systems Market

25.1. Canada Drug Infusion Systems Market Overview
25.2. Canada Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Infusion Systems Market

26.1. South America Drug Infusion Systems Market Overview
26.2. South America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Infusion Systems Market

27.1. Brazil Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Infusion Systems Market

28.1. Middle East Drug Infusion Systems Market Overview
28.2. Middle East Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Infusion Systems Market

29.1. Africa Drug Infusion Systems Market Overview
29.2. Africa Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Infusion Systems Market Competitive Landscape And Company Profiles

30.1. Drug Infusion Systems Market Competitive Landscape
30.2. Drug Infusion Systems Market Company Profiles
- 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. ICU Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Smiths Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug Infusion Systems Market Other Major And Innovative Companies

31.1. Tandem Diabetes Care Inc.
31.2. Terumo Corporation
31.3. Halyard Health Inc.
31.4. Insulet Corporation
31.5. Zyno Medical Inc.
31.6. Braun Melsungen AG
31.7. Flowonix Medical Inc.
31.8. IRadimed Corporation
31.9. Moog Inc.
31.10. Debiotech S.A.
31.11. Fresenius SE & Co. KGaA
31.12. Johnson & Johnson
31.13. Hospira
31.14. Alaris Health Systems Inc.
31.15. B. Braun Melsungen AG

32. Global Drug Infusion Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Infusion Systems Market

34. Recent Developments In The Drug Infusion Systems Market

35. Drug Infusion Systems Market High Potential Countries, Segments and Strategies

35.1 Drug Infusion Systems Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Infusion Systems Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Infusion Systems Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies